Status:
UNKNOWN
The Effect of Continuous Renal Replacement Therapy on the Efficiency of Extracorporeal CO2 Removal
Lead Sponsor:
Southeast University, China
Conditions:
Respiratory Failure With Hypercapnia
Eligibility:
All Genders
18-85 years
Brief Summary
In the design of extracorporeal carbon dioxide removal (ECCO2R) combined with continuous renal replacement therapy (CRRT) equipment, in model of continuous veno-venous hemofiltration (CVVH) , the HCO3...
Detailed Description
In the design of extracorporeal carbon dioxide removal (ECCO2R) combined with continuous renal replacement therapy (CRRT) equipment, the pre dilution replacement solution for continuous veno-venous he...
Eligibility Criteria
Inclusion
- Using Extracorporeal carbon dioxide removal combined with continuous renal replacement therapy
- 18 years ≤ age ≤ 85 years;
Exclusion
- Severe hemodynamic instability (increased dosage of vasoactive drugs or MAP ≤ 65mmHg within two hours);
- Severe electrolyte deficiency (including severe hyponatremia (blood sodium\<130mmol/L) and hypokalemia (blood potassium\<3.0mmol/L));
- Participate in other intervention studies within 30 days;
- Do not consent this research
Key Trial Info
Start Date :
April 24 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT05989971
Start Date
April 24 2023
End Date
December 1 2023
Last Update
August 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ling Liu
Nanjing, Jiangsu, China, 210009